---
title: "Weekly Recap | PURR.US -4.68%, consensus target sits above spot"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298793852.md"
description: "PURR.US closed the week at $11.61, down 4.68%, while the S&P 500 slipped 0.8%, leaving the stock about 3.88 percentage points behind the benchmark. Trading was choppy across the four sessions. It opened Tuesday at $11.73, touched a high of $12.74, fell as low as $10.96 on Thursday, then rebounded to $11.61 on Friday. The weekly range was 15.17%, and daily volume ran roughly 1.15 times the recent median, signalling heavier two-way positioning."
datetime: "2026-09-12T06:33:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298793852.md)
  - [en](https://longbridge.com/en/news/298793852.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298793852.md)
generator: "portal-rs"
---

# Weekly Recap | PURR.US -4.68%, consensus target sits above spot

## The Week

PURR.US closed the week at $11.61, down 4.68%, while the S&P 500 slipped 0.8%, leaving the stock about 3.88 percentage points behind the benchmark. Trading was choppy across the four sessions. It opened Tuesday at $11.73, touched a high of $12.74, fell as low as $10.96 on Thursday, then rebounded to $11.61 on Friday. The weekly range was 15.17%, and daily volume ran roughly 1.15 times the recent median, signalling heavier two-way positioning.

## Key Events

Activity on Hyperliquid’s derivatives platform stayed warm. On Monday, reports noted 373,952 active perpetual futures traders over the past 30 days, while ETF filings pointed to growing institutional exposure and HYPE hit a record high. The week’s price swings, though, sat against a backdrop of leveraged liquidations. BTC dropped to $77,600 on Wednesday, and on Thursday a Hyperliquid trader’s $1.15 million BTC and SOL position was liquidated. Friday’s intraday move of nearly 8% lower came alongside concern over 20x leveraged longs. Heading into the weekend, HIP-4 formally opened, and the stock bounced ahead of the Senate Clarity Act vote, even as commentary flagged regulatory uncertainty as the main risk.

## Analyst Ratings

Three brokers covered the stock this week: two at buy and one at overweight, with no neutral or sell ratings. The consensus rating is strong buy, with a consensus target of $23.73, about 104.4% above the latest price. Individual targets range from $17.00 to $34.20, so the spread is wide. Within its biotechnology peer group, the stock’s rating rank sits in the lower half at 377 out of 506, though the small sample narrows the usefulness of that ranking.

## The Week Ahead

US retail and manufacturing data dominate the calendar. The New York Fed manufacturing index lands Tuesday, followed Wednesday by retail sales, retail sales ex-autos, the import price index and the NAHB housing market index. Some retail readings carry negative prior prints and positive forecasts, so any beat would support the consumer narrative. Oil inventory data may also shift risk appetite. On the stock-specific side, watch the follow-through from the Senate Clarity Act vote and on-chain activity after HIP-4 opened.

## In Short

The week’s downside pressure centred on leveraged liquidations and short-term volatility fears. Volume expanded while the price fell, suggesting positioning is being reshuffled rather than abandoned. On the other side, brokers remain constructive, with a strong-buy consensus and a target more than double the current price, while the stock trades near 9x P/E and 1.2x book. The latest session’s flow showed small-lot money leaning to the sell side. The next question is whether leverage cools, how regulatory headlines resolve, and whether next week’s macro data reinforce risk appetite.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [PURR.US](https://longbridge.com/en/quote/PURR.US.md)

## Related News & Research

- [Jeff Yan Warned Bitget Could Become the Next FTX. Then Hyperliquid Faced Its Own FTX Moment](https://longbridge.com/en/news/300114529.md)
- [Ark Invest cast doubts on Hyperliquid’s U.S. plans – ‘Best casino in the world’](https://longbridge.com/en/news/300085735.md)
- [TECHNICALS-US oil may retest support at $88.78](https://longbridge.com/en/news/300892493.md)
- [Saudi Arabia unexpectedly cuts oil prices to Asia](https://longbridge.com/en/news/300887141.md)
- [Greg Abel-Led Berkshire Hathaway Owns 3 Consumer Stocks. Here's the One I'd Buy First.](https://longbridge.com/en/news/300873098.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**